Bayer Competitors

Stocks . Germany . 
Stock . Bayer AG NA
BAYN Stock   18.94  0.07  0.37%   
Bayer AG NA competes with Rayonier Advanced, Heidelberg Materials, Eagle Materials, Westinghouse Air, and NEWELL RUBBERMAID; as well as few others. The company operates under Healthcare sector and is part of Drug Manufacturers-General industry. Analyzing Bayer AG competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bayer AG to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Bayer AG Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bayer AG competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
16.5018.9421.38
Details
Intrinsic
Valuation
LowRealHigh
15.8718.3120.75
Details
Naive
Forecast
LowNextHigh
15.2217.6720.11
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
18.5719.4720.36
Details

Bayer AG Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bayer AG and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bayer and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bayer AG NA does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
WB2
+ 0.91
HEI
NWL
+ 0.9
HEI
NWL
+ 0.87
WB2
6C2
+ 0.74
NWL
6C2
+ 0.73
HEI
6C2
+ 0.73
WB2
  
High negative correlations   
NWC
- 0.44
WB2
NWC
- 0.41
NWL
NWC
- 0.3
HEI
WI20
- 0.23
E5M
NWC
- 0.23
E5M
NWC
- 0.21
RYQ

Risk-Adjusted Indicators

There is a big difference between Bayer Stock performing well and Bayer AG Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bayer AG's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Bayer AG Competitive Analysis

The better you understand Bayer AG competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bayer AG's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bayer AG's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BAYN RYQ HEI E5M WB2 NWL 6C2 NWC WI20
 0.37 
 18.94 
Bayer
 1.43 
 7.10 
Rayonier
 0.96 
 119.20 
Heidelberg
 1.67 
 236.00 
Eagle
 0.14 
 182.05 
Westinghouse
 2.27 
 9.47 
NEWELL
 1.89 
 6.22 
Corsair
 1.08 
 0.94 
Norwegian
 4.55 
 4.20 
WIZZ
Market Volatility
(90 Days Market Risk)
Not too volatile
Slightly risky
Very steady
Very steady
Very steady
Somewhat reliable
Moderately volatile
Extremely Dangerous
Risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Good
Very Weak
Good
Good
Weak
Very Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Quite High
Below Average
Low
Low
Low
Below Average
Quite High
Quite High
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Sell
Strong Hold
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Strong Sell
Strong Sell
Cautious Hold
Current Ratio
N/A
1.93
1.2
2.38
1.35
N/A
1.42
0.52
N/A
Net Asset
120.24 B
2.35 B
33.71 B
2.58 B
18.52 B
13.26 B
1.3 B
18.83 B
N/A
Profit Margin
0.0943
-0.0267
0.0756
0.21
0.0757
N/A
-0.0396
0.0533
-0.17
EBITDA
6.43 B
177 M
4.38 B
634.82 M
1.47 B
688 M
(1.06 M)
3.69 B
(356.48 M)
Operating Margin
0.23
-0.0021
0.1
0.26
0.13
N/A
-0.0395
-0.0316
-0.14
Current Valuation
82.93 B
1.2 B
17.1 B
5.81 B
21.22 B
10.91 B
1.72 B
1.03 B
N/A
Price To Book
1.35
0.68
0.62
4.27
1.87
1.47
2.98
1.65
N/A
Retained Earnings
N/A
N/A
8.67 B
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
7.81 B
N/A
N/A
N/A
N/A
N/A
N/A
Five Year Return
N/A
N/A
1.75
0.46
0.34
N/A
N/A
N/A
N/A
Beta
1.17
3.15
1.42
1.32
1.47
N/A
1.92
1.05
2.07
Number Of Employees
102.3 K
2.5 K
50.78 K
2.2 K
27 K
N/A
10
43
4.71 K
Shares Outstanding
982.42 M
63.97 M
193.09 M
36.05 M
180.35 M
N/A
101.49 M
931.59 M
413.07 M
Cash Flow From Operations
5.09 B
69 M
2.4 B
517.17 M
1.04 B
(272 M)
66.39 M
139.1 M
N/A
Annual Yield
0.0341
N/A
0.0369
0.0071
0.0066
0.0584
N/A
N/A
N/A
Total Debt
36.48 B
839 M
5.67 B
938.26 M
3.75 B
4.76 B
232.17 M
3.98 B
N/A
Return On Equity
0.13
-0.076
0.1
0.36
0.0629
N/A
-0.0882
0.27
-3.43
Z Score
0.6
N/A
1.2
3.0
2.4
0.6
5.2
N/A
N/A
Return On Asset
0.0576
-9.0E-4
0.0413
0.13
0.0362
N/A
-0.0258
-0.018
-0.0596
Book Value Per Share
42.01
12.19
88.89
32.16
55.75
N/A
6.15
4.52
0.68
Current Liabilities
N/A
N/A
8.67 B
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
120.24 B
2.35 B
33.71 B
2.58 B
18.52 B
13.26 B
1.3 B
18.83 B
N/A
Target Price
74.7
8.83
77.08
170.79
93.89
N/A
39.67
0.4
N/A
Last Dividend Paid
2.0
N/A
N/A
1.0
0.6
0.23
N/A
N/A
N/A
Debt To Equity
N/A
168.0
65.2
57.1
50.7
N/A
0.66
N/A
N/A
Shares Owned By Institutions
47.06
77.83
39.5
97.08
94.77
N/A
78.59
38.96
N/A
Market Capitalization
55.3 B
515.73 M
12.77 B
4.7 B
17.5 B
8.41 B
1.65 B
952.51 M
3.23 B
Price To Earnings To Growth
1.3
N/A
0.48
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
6.76
11.53
52.19
29.19
N/A
15.45
1.75
N/A
Price To Sales
0.99
0.32
0.5
2.28
2.11
0.57
0.94
0.0669
N/A
Net Income
1000 M
(15 M)
1.76 B
374.25 M
633 M
197 M
(54.39 M)
1.87 B
N/A
Earnings Per Share
4.77
-0.87
8.11
10.9
3.26
N/A
-0.6
0.01
-1.58
Shares Owned By Insiders
N/A
4.34
27.67
1.33
4.34
N/A
3.65
20.38
N/A
Revenue
44.08 B
1.72 B
18.72 B
1.86 B
8.36 B
9.46 B
1.38 B
5.07 B
3.48 B
Working Capital
N/A
N/A
(859 M)
N/A
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
4.56 B
110.16 M
2.6 B
8.6 M
512.87 M
N/A
121.62 M
790.84 M
N/A
Cash Per Share
N/A
2.24
13.1
0.19
3.15
N/A
1.32
20.43
N/A
Gross Profit
27.04 B
74.72 M
12.43 B
519.61 M
2.58 B
N/A
296.63 M
1.33 B
73.3 M
Day Typical Price
18.85
7.1
118.8
236.0
181.3
9.47
6.22
0.93
4.2
Accumulation Distribution
0.0252
N/A
0.0101
N/A
0.0124
N/A
N/A
0.0319
N/A
Market Facilitation Index
0.48
N/A
1.2
N/A
2.25
N/A
N/A
0.03
N/A
Daily Balance Of Power
0.1458
9.2 T
(0.96)
(9,223,372,036,855)
(0.11)
(9,223,372,036,855)
(9,223,372,036,855)
0.3333
(9,223,372,036,855)
Period Momentum Indicator
0.07
0.1
(1.15)
(4.00)
(0.25)
(0.22)
(0.12)
0.01
(0.20)
Rate Of Daily Change
1.0
1.01
0.99
0.98
1.0
0.98
0.98
1.01
0.95
Day Median Price
18.81
7.1
118.6
236.0
180.93
9.47
6.22
0.93
4.2
Price Action Indicator
0.17
0.05
0.025
(2.00)
1.0
(0.11)
(0.06)
0.02
(0.10)
Coefficient Of Variation
(410.65)
38675.75
535.17
(1,778)
638.41
639.64
2281.28
(8,430)
2622.59
Mean Deviation
1.46
2.15
1.17
1.42
0.955
2.53
2.97
2.38
3.21
Jensen Alpha
(0.60)
(0.01)
0.2696
(0.14)
0.2
0.6022
0.1879
(0.06)
0.1472
Total Risk Alpha
(0.67)
(0.10)
0.2358
(0.17)
0.1701
0.5015
0.0592
(0.14)
0.037
Sortino Ratio
N/A
(0.01)
0.218
N/A
0.196
0.2782
0.0456
N/A
0.0388
Downside Variance
N/A
7.28
1.39
N/A
0.911
4.51
12.23
N/A
13.96
Standard Deviation
2.44
3.68
1.55
1.86
1.4
3.99
4.37
3.31
4.64
Kurtosis
16.03
22.25
1.58
1.99
9.97
16.0
5.33
1.41
2.07
Potential Upside
1.74
3.68
2.83
3.52
2.03
5.95
8.18
5.88
10.89
Treynor Ratio
6.44
(0.0008)
0.6521
(0.11)
0.4999
1.25
(0.63)
(0.09)
0.1869
Maximum Drawdown
18.86
27.5
8.93
10.37
9.99
28.1
22.98
16.03
24.6
Variance
5.96
13.57
2.39
3.47
1.96
15.88
19.09
10.93
21.55
Market Risk Adjusted Performance
6.45
0.0092
0.6621
(0.1)
0.5099
1.26
(0.62)
(0.08)
0.1969
Risk Adjusted Performance
(0.19)
0.0099
0.1529
(0.04)
0.1284
0.1319
0.0429
(0)
0.0385
Skewness
(3.07)
3.62
0.8773
1.03
2.15
3.22
0.4197
(0.46)
1.05
Semi Deviation
N/A
2.43
0.846
N/A
0.7948
1.82
3.38
N/A
3.51
Information Ratio
(0.26)
(0.01)
0.1661
(0.07)
0.1336
0.1483
0.0365
(0.02)
0.0312
Value At Risk
(3.50)
(3.97)
(1.60)
(2.44)
(1.30)
(3.12)
(4.66)
(4.85)
(6.60)
Expected Short fall
N/A
(2.64)
(1.43)
N/A
(1.20)
(3.29)
(4.11)
N/A
(4.10)
Downside Deviation
N/A
2.7
1.18
N/A
0.9545
2.12
3.5
N/A
3.74
Semi Variance
N/A
5.93
0.7158
N/A
0.6318
3.3
11.44
N/A
12.31

Bayer AG Competition Performance Charts

Five steps to successful analysis of Bayer AG Competition

Bayer AG's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bayer AG NA in relation to its competition. Bayer AG's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bayer AG in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bayer AG's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bayer AG NA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bayer AG position

In addition to having Bayer AG in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Warren Buffett Holdings Thematic Idea Now

Warren Buffett Holdings
Warren Buffett Holdings Theme
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Bayer Stock

Bayer AG financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY